← Back to Search

Hearing Aid

Hearing Aid for Age-Related Hearing Loss (P-EARLHI Trial)

N/A
Recruiting
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at time of study enrollment; between 6- and 8-weeks post study enrollment; and at 6-months post study enrollment
Awards & highlights

P-EARLHI Trial Summary

This trial studies the effects of hearing aid intervention in adults 55-75 with hearing loss, to improve their physical, social, and quality of life outcomes.

Who is the study for?
This trial is for adults aged 55 to 75 who have early age-related hearing loss and haven't really used hearing aids before. They must be able to speak English or Spanish and fill out questionnaires on a tablet without help. People with certain cognitive issues that affect their ability to participate are not eligible.Check my eligibility
What is being tested?
The study is testing the Phonak Audeo Lumity Receiver in Canal Hearing Aid to see if it improves hearing outcomes in older adults. It's part of a bigger project aiming to understand how using high-quality hearing aids affects daily life, social activities, and overall well-being.See study design
What are the potential side effects?
While specific side effects aren't listed for this device, common issues with new hearing aids can include discomfort while wearing them, feedback noises, and an adjustment period where sounds may seem unusual or too loud.

P-EARLHI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at time of study enrollment; between 6- and 8-weeks post study enrollment; and at 6-months post study enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at time of study enrollment; between 6- and 8-weeks post study enrollment; and at 6-months post study enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Objective Physical Activity
Secondary outcome measures
Baecke Physical Activity Questionnaire
Center for Epidemiological Studies Depression and Hopelessness Scale
Client Oriented Scale of Improvement
+15 more

P-EARLHI Trial Design

1Treatment groups
Experimental Treatment
Group I: Hearing Intervention GroupExperimental Treatment1 Intervention
Adults aged 55-75 with hearing loss who have little/no prior experience with hearing aids will be enrolled in the hearing intervention group.

Find a Location

Who is running the clinical trial?

University of South FloridaLead Sponsor
412 Previous Clinical Trials
187,019 Total Patients Enrolled
8 Trials studying Hearing Loss
1,683 Patients Enrolled for Hearing Loss

Media Library

Phonak Audeo Lumity Receiver in Canal Hearing Aid (Hearing Aid) Clinical Trial Eligibility Overview. Trial Name: NCT05970211 — N/A
Hearing Loss Research Study Groups: Hearing Intervention Group
Hearing Loss Clinical Trial 2023: Phonak Audeo Lumity Receiver in Canal Hearing Aid Highlights & Side Effects. Trial Name: NCT05970211 — N/A
Phonak Audeo Lumity Receiver in Canal Hearing Aid (Hearing Aid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05970211 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly individuals aged 75 and above eligible for participation in this trial?

"The eligibility criteria for this trial stipulate that participants must be aged between 55 and 75."

Answered by AI

Is there an opportunity for me to join this clinical research?

"Eligibility requirements for this study necessitate that candidates are between 55 and 75 years old, as well as have hearing impairment. Ideally, 40 participants will join the trial."

Answered by AI

How many individuals have enrolled in this clinical study thus far?

"Affirmative. Clinicaltrials.gov records show that this trial, which was first advertised on June 19th 2023, is presently recruiting patients. 40 participants are needed from a single medical centre."

Answered by AI

Are any additional participants being admitted into this trial?

"Affirmative. Clinicaltrials.gov confirms that this trial, first posted on June 19th 2023, is actively looking for 40 patients from one centre to join in the research. The data was last updated on July 24th 2023."

Answered by AI
~22 spots leftby Apr 2025